Arca
Skip to content
Tools
Tools

Vecuronium

Small molecule that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Other 1

Approved1

  • Sugammadex

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        SugammadexApprovedMerck & Co. (MSD)OligosaccharideSequestering agentVecuronium sequestering agent29

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Comparison of NMTCuff and Standard TOF in Gynecologic Oncology Surgery (NMTCUFF-TOF)Sugammadex—RecruitingDr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalNov 9, 2026
        Sugammadex Timing and Recovery Profile in Pediatric AdenotonsillectomySugammadex—Not yet recruitingNamik Kemal UniversityOct 28, 2026
        Effect of Neuromuscular Blocking Agent Use on Video Laryngeal Mask Airway InsertionSugammadexPhase 4Not yet recruitingHacettepe UniversityOct 26, 2026
        REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential MonitoringSugammadexPhase 4Not yet recruitingMayo ClinicSep 22, 2026
        Precision TOF-Guided Sugammadex Versus Spontaneous Recovery for Early Extubation in Minimally Invasive Pediatric Cardiac SurgerySugammadex—RecruitingDr. Nguyen Thi Thu HangSep 1, 2026
        Deep Neuromuscular Blockade and a Low-Residue Diet for the Surgical Field in vNOTES HysterectomySugammadexNot applicableRecruitingFatih Sultan Mehmet Training and Research HospitalJul 28, 2026
        Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal TransplantationSugammadexNot applicableRecruitingUniversity of GaziantepJul 1, 2026
        Fentanyl and Rocuronium for Tracheal Intubation in NewbornsSugammadexPhase 4Not yet recruitingUEA - Universidade Do Estado Do AmazonasJun 16, 2026

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3559391, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.